Live Sunday, 2 August 2026

BREAKING

Egyptian FM holds calls with Iranian counterpart , U.S. Envoy on regional developmentsZverev into French Open last-fourIsraeli fire kills four people in Gaza, medics sayAncelotti eases Neymar W. Cup fearsArab, Islamic states condemn Israeli actions at Al-AqsaSyria Hopes for Terrorism Delisting to Spur Economic RecoveryBenfica linked with Fulham’s SilvaVan der Breggen takes Giro leadKremlin: Saudi Arabia Named Guest of Honor at St. Petersburg Economic Forumرياضة محلية‘Really cool to share this journey with her’: Michelle Wie West playing for her family at U.S. Women’s OpenArchaeological Replicas Showcase Saudi Arabia’s Rich History at Kuala Lumpur Int’l Book FairRenewable Energy Helps Red Sea Global Avoid 118,000 Tons of Carbon EmissionsLetter: Carol Rumens obituaryEngland v India: third and deciding women’s T20 cricket international – liveHealthVolunteers serve comfort food in a worrying Ebola outbreak – Sault Michigan NewsEconomyTrump signs AI executive order asking companies to give government early access to modelsVarietySouth West Water fined nearly £2million after supplying homes with parasite-ridden water that left four people in hospital – and telling people it was safe to drinkScience & TechYour car is following you – how to reclaim your data privacy on the open roadWorldHigh school valedictorian yanked from stage after hijacking speech to rant against Israel and ICESaudi FM Receives Written Message from Russian CounterpartEgyptian FM holds calls with Iranian counterpart , U.S. Envoy on regional developmentsZverev into French Open last-fourIsraeli fire kills four people in Gaza, medics sayAncelotti eases Neymar W. Cup fearsArab, Islamic states condemn Israeli actions at Al-AqsaSyria Hopes for Terrorism Delisting to Spur Economic RecoveryBenfica linked with Fulham’s SilvaVan der Breggen takes Giro leadKremlin: Saudi Arabia Named Guest of Honor at St. Petersburg Economic Forumرياضة محلية‘Really cool to share this journey with her’: Michelle Wie West playing for her family at U.S. Women’s OpenArchaeological Replicas Showcase Saudi Arabia’s Rich History at Kuala Lumpur Int’l Book FairRenewable Energy Helps Red Sea Global Avoid 118,000 Tons of Carbon EmissionsLetter: Carol Rumens obituaryEngland v India: third and deciding women’s T20 cricket international – liveHealthVolunteers serve comfort food in a worrying Ebola outbreak – Sault Michigan NewsEconomyTrump signs AI executive order asking companies to give government early access to modelsVarietySouth West Water fined nearly £2million after supplying homes with parasite-ridden water that left four people in hospital – and telling people it was safe to drinkScience & TechYour car is following you – how to reclaim your data privacy on the open roadWorldHigh school valedictorian yanked from stage after hijacking speech to rant against Israel and ICESaudi FM Receives Written Message from Russian Counterpart

Prices

US dollar51.12EGPEuro58.86EGPBritish pound68.81EGPSaudi riyal13.63EGPUAE dirham13.92EGPKuwaiti dinar165.21EGPJordanian dinar72.11EGPQatari riyal14.04EGPTurkish lira1.08EGPChinese yuan7.55EGPGold 246,646.42EGP/gGold 215,815.62EGP/gGold 184,984.82EGP/gSilver94.82EGP/g

US dollar51.12EGPEuro58.86EGPBritish pound68.81EGPSaudi riyal13.63EGPUAE dirham13.92EGPKuwaiti dinar165.21EGPJordanian dinar72.11EGPQatari riyal14.04EGPTurkish lira1.08EGPChinese yuan7.55EGPGold 246,646.42EGP/gGold 215,815.62EGP/gGold 184,984.82EGP/gSilver94.82EGP/g

Biotech

STAT+: Revolution Medicines starts shipping experimental pancreatic cancer drug

By STAT News · May 30, 2026 · 1 min read STAT News ↗

STAT+: Revolution Medicines starts shipping experimental pancreatic cancer drug

CHICAGO — The biotech company Revolution Medicines has begun sending its experimental, life-extending treatment for pancreatic cancer to physicians and their patients under an early access program authorized by the Food and Drug Administration, the company’s CEO, Mark Goldsmith, told STAT.

“We are now shipping the drug,” he said, speaking Friday evening at a STAT event held in conjunction with the annual meeting of the American Society of Clinical Oncology.

The drug, daraxonrasib, is not yet approved. But patients with pancreatic cancer have been clamoring for it since mid-April, when Revolution reported the striking results of a Phase 3 clinical trial. Patients treated with daraxonrasib lived nearly twice as long as patients offered standard chemotherapy — an outcome unprecedented in the pancreatic cancer field.

Continue to STAT+ to read the full story…

المصدر: STAT News

#ASCO #Biotech #Health #Pharma

0 Views

أضف تعليقاً Cancel reply